2024 -- S 2872  | |
========  | |
LC005694  | |
========  | |
STATE OF RHODE ISLAND  | |
IN GENERAL ASSEMBLY  | |
JANUARY SESSION, A.D. 2024  | |
____________  | |
A N A C T  | |
RELATING TO HEALTH AND SAFETY -- COMPREHENSIVE DISCHARGE PLANNING  | |
  | |
Introduced By: Senators Miller, Lawson, DiPalma, DiMario, Lauria, and Ujifusa  | |
Date Introduced: March 22, 2024  | |
Referred To: Senate Health & Human Services  | |
It is enacted by the General Assembly as follows:  | |
1  | SECTION 1. Section 23-17.26-3 of the General Laws in Chapter 23-17.26 entitled  | 
2  | "Comprehensive Discharge Planning" is hereby amended to read as follows:  | 
3  | 23-17.26-3. Comprehensive discharge planning.  | 
4  | (a) On or before January 1, 2017, each hospital and freestanding emergency-care facility  | 
5  | operating in the state of Rhode Island shall submit to the director a comprehensive discharge plan  | 
6  | that includes:  | 
7  | (1) Evidence of participation in a high-quality, comprehensive discharge-planning and  | 
8  | transitions-improvement project operated by a nonprofit organization in this state; or  | 
9  | (2) A plan for the provision of comprehensive discharge planning and information to be  | 
10  | shared with patients transitioning from the hospital’s or freestanding emergency-care facility’s  | 
11  | care. Such plan shall contain the adoption of evidence-based practices including, but not limited to:  | 
12  | (i) Providing education in the hospital or freestanding emergency-care facility prior to  | 
13  | discharge;  | 
14  | (ii) Ensuring patient involvement such that, at discharge, patients and caregivers  | 
15  | understand the patient’s conditions and medications and have a point of contact for follow-up  | 
16  | questions;  | 
17  | (iii) Encouraging notification of the person(s) listed as the patient’s emergency contacts  | 
18  | and certified peer recovery specialist to the extent permitted by lawful patient consent or applicable  | 
19  | law, including, but not limited to, the Federal Health Insurance Portability and Accountability Act  | 
  | |
1  | of 1996, as amended, and 42 C.F.R. Part 2, as amended. The policy shall also require all attempts  | 
2  | at notification to be noted in the patient’s medical record;  | 
3  | (iv) Attempting to identify patients’ primary care providers and assisting with scheduling  | 
4  | post-discharge follow-up appointments prior to patient discharge;  | 
5  | (v) Expanding the transmission of the department of health’s continuity-of-care form, or  | 
6  | successor program, to include primary care providers’ receipt of information at patient discharge  | 
7  | when the primary care provider is identified by the patient; and  | 
8  | (vi) Coordinating and improving communication with outpatient providers.  | 
9  | (3) The discharge plan and transition process shall include recovery planning tools for  | 
10  | patients with substance use disorders, opioid overdoses, and chronic addiction, which plan and  | 
11  | transition process shall include the elements contained in subsection (a)(1) or (a)(2), as applicable.  | 
12  | In addition, such discharge plan and transition process shall also include:  | 
13  | (i) That, with patient consent, each patient presenting to a hospital or freestanding  | 
14  | emergency-care facility with indication of a substance use disorder, opioid overdose, or chronic  | 
15  | addiction shall receive a substance use evaluation, in accordance with the standards in subsection  | 
16  | (a)(4)(ii), before discharge. Prior to the dissemination of the standards in subsection (a)(4)(ii), with  | 
17  | patient consent, each patient presenting to a hospital or freestanding emergency-care facility with  | 
18  | indication of a substance use disorder, opioid overdose, or chronic addiction shall receive a  | 
19  | substance use evaluation, in accordance with best practices standards, before discharge;  | 
20  | (ii) That if, after the completion of a substance use evaluation, in accordance with the  | 
21  | standards in subsection (a)(4)(ii), the clinically appropriate inpatient and outpatient services for the  | 
22  | treatment of substance use disorders, opioid overdose, or chronic addiction contained in subsection  | 
23  | (a)(3)(iv) are not immediately available, the hospital or freestanding emergency-care facility shall  | 
24  | provide medically necessary and appropriate services with patient consent, until the appropriate  | 
25  | transfer of care is completed;  | 
26  | (iii) That, with patient consent, pursuant to 21 C.F.R. § 1306.07, a physician in a hospital  | 
27  | or freestanding emergency-care facility, who is not specifically registered to conduct a narcotic  | 
28  | treatment program, may administer narcotic drugs, including buprenorphine, to a person for the  | 
29  | purpose of relieving acute, opioid-withdrawal symptoms, when necessary, while arrangements are  | 
30  | being made for referral for treatment. Not more than one day’s medication may be administered to  | 
31  | the person or for the person’s use at one time. Such emergency treatment may be carried out for  | 
32  | not more than three (3) days and may not be renewed or extended;  | 
33  | (iv) That each patient presenting to a hospital or freestanding emergency-care facility with  | 
34  | indication of a substance use disorder, opioid overdose, or chronic addiction, shall receive  | 
  | LC005694 - Page 2 of 8  | 
1  | information, made available to the hospital or freestanding emergency-care facility in accordance  | 
2  | with subsection (a)(4)(v), about the availability of clinically appropriate inpatient and outpatient  | 
3  | services for the treatment of mental health disorders, including substance use disorders, opioid  | 
4  | overdose, or chronic addiction, including:  | 
5  | (A) Detoxification;  | 
6  | (B) Stabilization;  | 
7  | (C) Medication-assisted treatment or medication-assisted maintenance services, including  | 
8  | methadone, buprenorphine, naltrexone, or other clinically appropriate medications;  | 
9  | (D) Inpatient Outpatient, inpatient and residential treatment;  | 
10  | (E) Licensed clinicians with expertise in the treatment of substance use disorders, opioid  | 
11  | overdoses, and chronic addiction; and  | 
12  | (F) Certified peer recovery specialists; and.  | 
13  | (v) That, when the real-time patient-services database outlined in subsection (a)(4)(vi)  | 
14  | becomes available, each patient shall receive real-time information from the hospital or  | 
15  | freestanding emergency-care facility about the availability of clinically appropriate inpatient and  | 
16  | outpatient services.  | 
17  | (4) On or before January 1, 2017, the director of the department of health, with the director  | 
18  | of the department of behavioral healthcare, developmental disabilities and hospitals, shall:  | 
19  | (i) Develop and disseminate, to all hospitals and freestanding emergency-care facilities, a  | 
20  | regulatory standard for the early introduction of a certified peer recovery specialist during the pre-  | 
21  | admission and/or admission process for patients with substance use disorders, opioid overdose, or  | 
22  | chronic addiction;  | 
23  | (ii) Develop and disseminate, to all hospitals and freestanding emergency-care facilities,  | 
24  | substance use evaluation standards for patients with substance use disorders, opioid overdose, or  | 
25  | chronic addiction;  | 
26  | (iii) Develop and disseminate, to all hospitals and freestanding emergency-care facilities,  | 
27  | pre-admission, admission, and discharge regulatory standards, a recovery plan, and voluntary  | 
28  | transition process for patients with substance use disorders, opioid overdose, or chronic addiction.  | 
29  | Recommendations from the 2015 Rhode Island governor’s overdose prevention and intervention  | 
30  | task force strategic plan may be incorporated into the standards as a guide, but may be amended  | 
31  | and modified to meet the specific needs of each hospital and freestanding emergency-care facility;  | 
32  | (iv) Develop and disseminate best practices standards for healthcare clinics, urgent-care  | 
33  | centers, and emergency-diversion facilities regarding protocols for patient screening, transfer, and  | 
34  | referral to clinically appropriate inpatient and outpatient services contained in subsection (a)(3)(iv);  | 
  | LC005694 - Page 3 of 8  | 
1  | (v) Develop regulations for patients presenting to hospitals and freestanding emergency-  | 
2  | care facilities with indication of a substance use disorder, opioid overdose, or chronic addiction to  | 
3  | ensure prompt, voluntary access to clinically appropriate inpatient and outpatient services  | 
4  | contained in subsection (a)(3)(iv);  | 
5  | (vi) Develop a strategy to assess, create, implement, and maintain a database of real-time  | 
6  | availability of clinically appropriate inpatient and outpatient services contained in subsection  | 
7  | (a)(3)(iv) of this section on or before January 1, 2018.  | 
8  | (b) Nothing contained in this chapter shall be construed to limit the permitted disclosure of  | 
9  | confidential healthcare information and communications permitted in § 5-37.3-4(b)(4)(i) of the  | 
10  | confidentiality of health care communications act.  | 
11  | (c) On or before September 1, 2017, each hospital and freestanding emergency-care facility  | 
12  | operating in the state of Rhode Island shall submit to the director a discharge plan and transition  | 
13  | process that shall include provisions for patients with a primary diagnosis of a mental health  | 
14  | disorder without a co-occurring substance use disorder.  | 
15  | (d) On or before January 1, 2018, the director of the department of health, with the director  | 
16  | of the department of behavioral healthcare, developmental disabilities and hospitals, shall develop  | 
17  | and disseminate mental health best practices standards for healthcare clinics, urgent care centers,  | 
18  | and emergency diversion facilities regarding protocols for patient screening, transfer, and referral  | 
19  | to clinically appropriate inpatient and outpatient services. The best practice standards shall include  | 
20  | information and strategies to facilitate clinically appropriate prompt transfers and referrals from  | 
21  | hospitals and freestanding emergency-care facilities to less intensive settings.  | 
22  | (e) The director of the department of health, with the director of the department of  | 
23  | behavioral healthcare, developmental disabilities and hospitals, shall utilize the real-time database  | 
24  | created under § 23-17.26-3(a)(4)(vi), and develop and implement a plan to ensure that patients with  | 
25  | mental health disorders, including substance use disorders, who are in need of, and agree to,  | 
26  | clinically appropriate and medically necessary residential, inpatient, or outpatient services are  | 
27  | discharged from hospitals and freestanding emergency-care facilities into such settings as  | 
28  | expeditiously as possible.  | 
29  | (f) On or before March l, 2028, the senate and house committees on health and human  | 
30  | services and/or any other committee deemed appropriate by the president of the senate and the  | 
31  | speaker of the house of representatives shall conduct a hearing on the impact of subsection (e) of  | 
32  | this section to include presentations from payors and providers, and other stakeholders at the  | 
33  | discretion of the committee chairs.  | 
34  | SECTION 2. Chapter 23-17.26 of the General Laws entitled "Comprehensive Discharge  | 
  | LC005694 - Page 4 of 8  | 
1  | Planning" is hereby amended by adding thereto the following section:  | 
2  | 23-17.26-5. Comprehensive patient consent form.  | 
3  | Each hospital and freestanding emergency-care facility shall incorporate patient consent  | 
4  | for certified peer recovery specialist services into a comprehensive patient consent form. Consent  | 
5  | for certified peer recovery services shall be contained in its own discrete section of the  | 
6  | comprehensive patient consent form. This section shall be implemented no later than January 1,  | 
7  | 2025.  | 
8  | SECTION 3. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled "Insurance  | 
9  | Coverage for Mental Illness and Substance Use Disorders" is hereby amended to read as follows:  | 
10  | 27-38.2-1. Coverage for treatment of mental health and substance use disorders  | 
11  | Coverage for treatment of mental health disorders, including substance use disorders.  | 
12  | (a) A group health plan and an individual or group health insurance plan, and any contract  | 
13  | between the Rhode Island Medicaid program and any health insurance carrier, as defined under  | 
14  | chapters 18, 19, 20, and 41 of title 27, shall provide coverage for the treatment of mental health and  | 
15  | substance use disorders under the same terms and conditions as that coverage is provided for other  | 
16  | illnesses and diseases.  | 
17  | (b) Coverage for the treatment of mental health and disorders, including substance use  | 
18  | disorders shall not impose any annual or lifetime dollar limitation.  | 
19  | (c) Financial requirements and quantitative treatment limitations on coverage for the  | 
20  | treatment of mental health and disorders, including substance use disorders shall be no more  | 
21  | restrictive than the predominant financial requirements applied to substantially all coverage for  | 
22  | medical conditions in each treatment classification.  | 
23  | (d) Coverage shall not impose be subject to non-quantitative treatment limitations for the  | 
24  | treatment of mental health and disorders, including substance use disorders unless the processes,  | 
25  | strategies, evidentiary standards, or other factors used in applying the non-quantitative treatment  | 
26  | limitation, as written and in operation, are comparable to, and are applied no more stringently than,  | 
27  | the processes, strategies, evidentiary standards, or other factors used in applying the limitation with  | 
28  | respect to medical/surgical benefits in the classification.  | 
29  | (e) The following classifications shall be used to apply the coverage requirements of this  | 
30  | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4)  | 
31  | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs.  | 
32  | (f) Medication-assisted treatment or medication-assisted maintenance services of substance  | 
33  | use disorders, opioid overdoses, and chronic addiction, including methadone, buprenorphine,  | 
34  | naltrexone, or other clinically appropriate medications, is included within the appropriate  | 
  | LC005694 - Page 5 of 8  | 
1  | classification based on the site of the service.  | 
2  | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine when  | 
3  | developing coverage for levels of care and determining placements for substance use disorder  | 
4  | treatment.  | 
5  | (h) Patients with substance use disorders shall have access to evidence-based, non-opioid  | 
6  | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and  | 
7  | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2.  | 
8  | (i) Parity of cost-sharing requirements. Regardless of the professional license of the  | 
9  | provider of care, if that care is consistent with the provider’s scope of practice and the health plan’s  | 
10  | credentialing and contracting provisions, cost sharing for behavioral health counseling visits and  | 
11  | medication maintenance visits shall be consistent with the cost sharing applied to primary care  | 
12  | office visits.  | 
13  | (j) Consistent with coverage for medical and surgical services, a health plan as defined in  | 
14  | subsection (a) of this section shall cover clinically appropriate and medically necessary residential  | 
15  | or inpatient services, including detoxification and stabilization services, for the treatment of mental  | 
16  | health disorders, including substance use disorders, in accordance with this subsection.  | 
17  | (1) The health plan shall provide coverage for clinically appropriate and medically  | 
18  | necessary residential or inpatient services, including American Society of Addiction Medicine  | 
19  | levels of care for residential and inpatient services, and shall not require preauthorization prior to a  | 
20  | patient obtaining such services, provided that the facility shall provide the health plan notification  | 
21  | of admission, proof that an assessment was conducted based upon the criteria of the American  | 
22  | Society of Addiction Medicine or after an appropriate psychiatric assessment for mental health  | 
23  | disorders, that residential or inpatient services is the most appropriate and least restrictive level of  | 
24  | care necessary, the initial treatment plan, and estimated length of stay within forty-eight hours (48)  | 
25  | of admission.  | 
26  | (2) Notwithstanding § 27-38.2-3, coverage provided under this subsection shall not be  | 
27  | subject to concurrent utilization review during the first twenty-eight (28) days of the residential or  | 
28  | inpatient admission provided that the facility notifies the health plan as provided in subsection (j)(1)  | 
29  | of this section. The facility shall perform daily clinical review of the patient, including consultation  | 
30  | with the health plan at, or just prior to, the fourteenth day of treatment to ensure that the facility  | 
31  | determined that the residential or inpatient treatment was clinically appropriate and medically  | 
32  | necessary for the patient using an assessment based upon the criteria of the American Society of  | 
33  | Addiction Medicine or after an appropriate psychiatric assessment for mental health disorders.  | 
34  | (3) Prior to discharge from residential or inpatient services, the facility shall provide the  | 
  | LC005694 - Page 6 of 8  | 
1  | patient and the health plan with a written discharge plan which shall describe arrangements for  | 
2  | additional services needed following discharge from the residential or inpatient facility as  | 
3  | determined using an assessment based upon the criteria of the American Society of Addiction  | 
4  | Medicine or after an appropriate psychiatric assessment for mental health disorders. Prior to  | 
5  | discharge, the facility shall indicate to the health plan whether services included in the discharge  | 
6  | plan are secured or determined to be reasonably available. The health plan may conduct utilization  | 
7  | review procedures, in consultation with the patient’s treating clinician, regarding the discharge plan  | 
8  | and continuation of care.  | 
9  | (4) Any utilization review of treatment provided under this subsection may include a  | 
10  | review of all services provided during such residential or inpatient treatment, including all services  | 
11  | provided during the first twenty-eight (28) days of such residential or inpatient treatment. Provided,  | 
12  | however, the health plan shall only deny coverage for any portion of the initial twenty-eight (28)  | 
13  | days of residential or inpatient treatment on the basis that such treatment was not medically  | 
14  | necessary if such residential or inpatient treatment was contrary to the assessment based upon the  | 
15  | criteria of the American Society of Addiction Medicine or after an appropriate psychiatric  | 
16  | assessment for mental health disorders. A patient shall not have any financial obligation to the  | 
17  | facility for any treatment under this subsection other than any copayment, coinsurance, or  | 
18  | deductible otherwise required under the policy.  | 
19  | (5) This subsection shall apply only to covered services delivered within the health plan’s  | 
20  | provider network.  | 
21  | (6) Nothing herein prohibits the health plan from conducting quality of care reviews.  | 
22  | (k) No health plan as defined in subsection (a) of this section shall refuse to cover treatment  | 
23  | for mental health disorders, including substance use disorders, regardless of the level of care, that  | 
24  | such health plan is required to cover pursuant to this section solely because such treatment is  | 
25  | ordered by a court of competent jurisdiction or by a government operated diversion program.  | 
26  | (l) On or before March l, 2028, the senate and house committees on health and human  | 
27  | services and/or any other committee deemed appropriate by the president of the senate and the  | 
28  | speaker of the house of representatives shall conduct a hearing on the impact of subsections (j) and  | 
29  | (k) of this section to include presentations from payors and providers, and other stakeholders at the  | 
30  | discretion of the committee chairs.  | 
31  | SECTION 4. This act shall take effect on January 1, 2025.  | 
========  | |
LC005694  | |
========  | |
  | LC005694 - Page 7 of 8  | 
EXPLANATION  | |
BY THE LEGISLATIVE COUNCIL  | |
OF  | |
A N A C T  | |
RELATING TO HEALTH AND SAFETY -- COMPREHENSIVE DISCHARGE PLANNING  | |
***  | |
1  | This act would require a health plan to cover clinically appropriate and medically necessary  | 
2  | residential or inpatient services, including detoxification and stabilization services, for the  | 
3  | treatment of mental health disorders, including substance use disorders. A health plan shall not  | 
4  | require preauthorization prior to a patient obtaining such services provided certain notifications are  | 
5  | provided to the health plan within forty-eight hours (48) of admission. This act would also provide  | 
6  | that such coverage shall not be subject to concurrent utilization review during the first twenty-eight  | 
7  | (28) days of the residential or inpatient admission.  | 
8  | This act would take effect on January 1, 2025.  | 
========  | |
LC005694  | |
========  | |
  | LC005694 - Page 8 of 8  |